OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients.
METHODS: After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached.
RESULTS: A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening.
|Translated title of the contribution
|Screening auf mit rheumatoider Arthritis assoziierte interstitielle Lungenerkrankung – Delphi-basiertes Konsensus-Statement
|Zeitschrift fur Rheumatologie
|Early online date
|19 Jan 2024
|E-pub ahead of print - 19 Jan 2024
- Antifibrotic agents
- Autoimmune diseases
- Mass screening
- Risk factors
ASJC Scopus subject areas